COVID-19 and emerging viral infections: The case for interferon lambda

With the first reports on coronavirus disease 2019 (COVID-19), which is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the scientific community working in the field of type III IFNs (IFN-λ) realized that this class of IFNs could play an important role in this and o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Exp Med
Hlavní autoři: Prokunina-Olsson, Ludmila, Alphonse, Noémie, Dickenson, Ruth E., Durbin, Joan E., Glenn, Jeffrey S., Hartmann, Rune, Kotenko, Sergei V., Lazear, Helen M., O’Brien, Thomas R., Odendall, Charlotte, Onabajo, Olusegun O., Piontkivska, Helen, Santer, Deanna M., Reich, Nancy C., Wack, Andreas, Zanoni, Ivan
Médium: Artigo
Jazyk:Inglês
Vydáno: Rockefeller University Press 2020
Témata:
Viewpoint
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7155807/
https://ncbi.nlm.nih.gov/pubmed/32289152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20200653
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky